EARLY DETECTION OF AMINOGLYCOSIDE NEPHROTOXICITY WITH URINARY BETA-2-MICROGLOBULIN
- 1 January 1978
- journal article
- research article
- Vol. 9 (3) , 201-210
Abstract
A radioimmunoassay was used to evaluate the changes in the urinary excretion of .beta.2-microglobulin (.beta.2M) in 21 patients receiving aminoglycosides for treatment of infection. Excretion of this protein rose to a peak at least 5 .times. the baseline value in the urine, and declined rapidly to control values after drug administration ceased. In 6 patients who developed aminoglycoside nephrotoxicity, urinary .beta.2M excretion rose 5 days or more before serum creatinine rose and 5 of 6 nephrotoxic patients excreted more than 50 mg/day (normal, < 0.1 mg/day). Urinary .beta.2M is a non-specific indication of renal tubular damage, but heralds aminoglycoside-induced damage before standard tests of kidney function change.This publication has 5 references indexed in Scilit:
- Renal Tubular Dysfunction in Minamata DiseaseAnnals of Internal Medicine, 1977
- Aminoglycoside antibiotics and renal function: changes in urinary gamma-glutamyltransferase excretion.Journal of Clinical Pathology, 1977
- Enzymes of renal origin in urine as indicators of nephrotoxicity*1Toxicology and Applied Pharmacology, 1977
- Acute renal successThe American Journal of Medicine, 1976
- Renal damage caused by gentamicin: A study of the effects on renal morphology and urinary enzyme excretionThe Journal of Pathology, 1976